These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36749528)

  • 21. Cardiovascular safety profile and clinical experience with high-dose domperidone therapy for nausea and vomiting.
    Ortiz A; Cooper CJ; Alvarez A; Gomez Y; Sarosiek I; McCallum RW
    Am J Med Sci; 2015 May; 349(5):421-4. PubMed ID: 25828198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Domperidone treatment for gastroparesis: demographic and pharmacogenetic characterization of clinical efficacy and side-effects.
    Parkman HP; Jacobs MR; Mishra A; Hurdle JA; Sachdeva P; Gaughan JP; Krynetskiy E
    Dig Dis Sci; 2011 Jan; 56(1):115-24. PubMed ID: 21063774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between domperidone use and adverse cardiovascular events: A nested case-control and case-time-control study.
    Shin SM; Jeong HE; Lee H; Shin JY
    Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1636-1649. PubMed ID: 32869447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac safety and clinical efficacy of high-dose domperidone for long-term treatment of gastroparesis symptoms.
    Woods K; Gajendran M; Gonzalez Z; Bustamante-Bernal M; Sarosiek I; Espino K; Waterhouse N; Siddiqui T; McCallum R
    J Investig Med; 2022 Jun; 70(5):1225-1232. PubMed ID: 35217570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metoclopramide or domperidone for increasing maternal breast milk output: a randomised controlled trial.
    Ingram J; Taylor H; Churchill C; Pike A; Greenwood R
    Arch Dis Child Fetal Neonatal Ed; 2012 Jul; 97(4):F241-5. PubMed ID: 22147287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Domperidone is Commonly Prescribed With QT-Interacting Drugs: Review of a Community-based Practice and a Postmarketing Adverse Drug Event Reporting Database.
    Ehrenpreis ED; Roginsky G; Alexoff A; Smith DG
    J Clin Gastroenterol; 2017 Jan; 51(1):56-62. PubMed ID: 27182647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D₂-receptor antagonists ameliorate indomethacin-induced small intestinal ulceration in mice by activating α7 nicotinic acetylcholine receptors.
    Yasuda M; Kawahara R; Hashimura H; Yamanaka N; Iimori M; Amagase K; Kato S; Takeuchi K
    J Pharmacol Sci; 2011; 116(3):274-82. PubMed ID: 21691039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis.
    Bielefeldt K
    Dig Dis Sci; 2017 Nov; 62(11):2999-3013. PubMed ID: 28577245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological Approaches to Diabetic Gastroparesis: A systematic review of randomised clinical trials.
    Asha MZ; Khalil SFH
    Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e291-e304. PubMed ID: 31897312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic gastroparesis.
    Tarsy D
    N Engl J Med; 2007 Jul; 357(4):419; author reply 419-20. PubMed ID: 17663032
    [No Abstract]   [Full Text] [Related]  

  • 31. Metoclopramide for the treatment of diabetic gastroparesis.
    Shakhatreh M; Jehangir A; Malik Z; Parkman HP
    Expert Rev Gastroenterol Hepatol; 2019 Aug; 13(8):711-721. PubMed ID: 31314613
    [No Abstract]   [Full Text] [Related]  

  • 32. [Proarrhythmic effects of domperidone in infants: a systematic review].
    Caraballo L; Molina G; Weitz D; Piskulic L; Avila A; Marzi M
    Farm Hosp; 2014 Sep; 38(5):438-44. PubMed ID: 25344138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metoclopramide nasal spray (Gimoti) for diabetic gastroparesis.
    Med Lett Drugs Ther; 2021 Jan; 63(1615):5-7. PubMed ID: 33646999
    [No Abstract]   [Full Text] [Related]  

  • 34. Response and Adverse Event Rates With Placebo in Gastroparesis: A Systematic Review and Meta-analysis.
    Wise JL; Ingrosso MR; Ianiro G; Black CJ; Ford AC; Lacy BE
    Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1447-1461. PubMed ID: 36270614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group.
    Silvers D; Kipnes M; Broadstone V; Patterson D; Quigley EM; McCallum R; Leidy NK; Farup C; Liu Y; Joslyn A
    Clin Ther; 1998; 20(3):438-53. PubMed ID: 9663360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia.
    Prescrire Int; 2016 Oct; 25(175):238-240. PubMed ID: 30645828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis.
    Sugumar A; Singh A; Pasricha PJ
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):726-33. PubMed ID: 18524689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis.
    Dumitrascu DL; Weinbeck M
    Am J Gastroenterol; 2000 Jan; 95(1):316-7. PubMed ID: 10638616
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.
    Arana A; Johannes CB; McQuay LJ; Varas-Lorenzo C; Fife D; Rothman KJ
    Drug Saf; 2015 Dec; 38(12):1187-99. PubMed ID: 26350642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natalizumab for induction of remission in Crohn's disease.
    Nelson SM; Nguyen TM; McDonald JW; MacDonald JK
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006097. PubMed ID: 30068022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.